Neurotoxicity of Ecstasy Metabolites in Rat Cortical Neurons, and Influence of Hyperthermia

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2006-01-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.TOXLET.2006.06.248PMID 16183702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serotonergic Neurotoxic Metabolites of Ecstasy Identified in Rat Brain

  2005cited by this paper
• Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy

  2005cited by this paper
• The toxicity of N-methyl-α-methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine

  2004cited by this paper
• Metabolism is required for the expression of ecstasy-induced cardiotoxicity in vitro.

  2004cited by this paper
• Hepatotoxicity of 3,4-methylenedioxyamphetamine and α-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates

  2004cited by this paper
• The Role of Metabolism in 3,4-(±)-Methylenedioxyamphetamine and 3,4-(±)-Methylenedioxymethamphetamine (Ecstasy) toxicity

  2004influential reference
• Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA.

  2003cited by this paper
• Tissue concentrations of MDMA and its metabolite MDA in three fatal cases of overdose.

  2003influential reference
• The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

  2003influential reference
• Cu2+-induced isoproterenol oxidation into isoprenochrome in adult rat calcium-tolerant cardiomyocytes.

  2002cited by this paper
• Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity.

  2002cited by this paper
• 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose

  2001cited by this paper
• 3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans.

  2001cited by this paper
• Role of nitric oxide in the ethylcholine aziridinium model of delayed apoptotic neurodegeneration in vivo and in vitro.

  2000cited by this paper
• Role of quinones in toxicology.

  2000cited by this paper
• (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals

  2000influential reference
• Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity.

  1999influential reference
• Amphetamines induce apoptosis and regulation of bcl‐x splice variants in neocortical neurons

  1999cited by this paper
• N‐tert‐butyl‐alpha‐phenylnitrone protects against 3,4‐methylenedioxymethamphetamine‐induced depletion of serotonin in rats

  1999cited by this paper
• Immunochemical detection of quinol--thioether-derived protein adducts.

  1998cited by this paper
• The abused drug MDMA (Ecstasy) induces programmed death of human serotonergic cells

  1997cited by this paper
• In vivo evidence for free radical involvement in the degeneration of rat brain 5‐HT following administration of MDMA (‘ecstasy’) and p‐chloroamphetamine but not the degeneration following fenfluramine

  1997cited by this paper
• 2,5-Bis-(glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of (+/-)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations.

  1997cited by this paper
• Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion.

  1996influential reference
• Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats.

  1996influential reference
• The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.

  1995cited by this paper
• Metabolism of 5-(glutathion-S-yl)-alpha-methyldopamine following intracerebroventricular administration to male Sprague-Dawley rats.

  1995cited by this paper
• Effects of L-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson's disease.

  1994cited by this paper
• Reactive Oxygen Species and the Central Nervous System

  1992cited by this paper
• Biochemical and toxicological properties of the oxidation products of catecholamines.

  1992cited by this paper
• Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA).

  1992cited by this paper
• Ecstasy and the dance of death.

  1992cited by this paper
• Hydroxyl radical mediated demethylenation of (methylenedioxy)phenyl compounds.

  1991cited by this paper
• Evidence for carrier-mediated transport of glutathione across the blood-brain barrier in the rat.

  1990cited by this paper
• Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct.

  1990cited by this paper
• In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat: identification of metabolites using an ion trap detector.

  1988cited by this paper
• Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.

  1987cited by this paper
• Alpha-methyldopamine derivatives. Synthesis and pharmacology.

  1974cited by this paper

• Severe 3,4-Methylenedioxymethamphetamine (MDMA)-Associated Rhabdomyolysis in Crohn’s Disease: Direct Toxicity and Inflammatory Susceptibility in the Absence of Hyperthermia

  2026cites this paper
• Next-Generation MDMA Analogue SDMA: Pharmacological and Metabolic Insights

  2025cites this paper
• Bioisosteric analogs of MDMA with improved pharmacological profile

  2024cites this paper
• Bioisosteric analogs of MDMA: Improving the pharmacological profile?

  2024cites this paper
• Brain dysfunctions and neurotoxicity induced by psychostimulants in experimental models and humans: an overview of recent findings

  2023cites this paper
• Study of the potential toxicity of adrenaline to neurons, using the SH-SY5Y human cellular model

  2023cites this paper
• A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)

  2022cites this paper
• A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)

  2022cites this paper
• Ecstasy metabolites and monoamine neurotransmitters upshift the Na+/K+ ATPase activity in mouse brain synaptosomes

  2022cites this paper
• Protective effects of atorvastatin and rosuvastatin on 3,4-methylenedioxymethamphetamine (MDMA)-induced spatial learning and memory impairment

  2021cites this paper
• Cognitive consequences of 3,4-methylenedioxymethamphetamine use

  2020cites this paper
• Lysosomal dysfunction and autophagy blockade contribute to MDMA-induced neurotoxicity in SH-SY5Y neuroblastoma cells.

  2020cites this paper
• MDMA hepatotoxicity under heat stress condition: novel insights from in vitro metabolomic studies.

  2020cites this paper
• Increased iNOS and Nitrosative Stress in Dopaminergic Neurons of MDMA-Exposed Rats

  2019cites this paper
• Neuroprotective Effect of Pentoxifylline on 3,4-Methylenedioxymethamphetamine-Induced Apoptosis in CA1 Cells of Wistar Rat Hippocampus

  2019cites this paper
• Structure-cytotoxicity relationship profile of 13 synthetic cathinones in differentiated human SH-SY5Y neuronal cells.

  2019cites this paper
• Protective Effects of Vitamin E on Heart and Testis Histology Following MDMA (Ecstasy) Exposure in Mice

  2019cites this paper
• Aged rats are more vulnerable than adolescents to “ecstasy”-induced toxicity

  2018cites this paper
• Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.

  2018cites this paper
• Amphetamine‐related drugs neurotoxicity in humans and in experimental animals: Main mechanisms

  2017influential citation
• Hyperthermia Severely Affects the Vascular Effects of MDMA and Metabolites in the Human Internal Mammary Artery In Vitro

  2017cites this paper
• Uncovering the hepatotoxic and neurotoxic potential of ß-keto amphetamine (cathinone) derivates: in vitro mechanistic studies.

  2017influential citation
• “Ecstasy” toxicity to adolescent rats following an acute low binge dose

  2016cites this paper
• Influence of different neuroprotective drugs on dopamine neurotoxicity induced by 3,4-methylenedioxymethamphetamine and MPTP in mice

  2016cites this paper
• Editor's Highlight: Characterization of Hepatotoxicity Mechanisms Triggered by Designer Cathinone Drugs (β-Keto Amphetamines).

  2016cites this paper
• Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy

  2016cites this paper
• In vitro models for neurotoxicology research

  2015cites this paper
• The neurotoxicity of amphetamines during the adolescent period

  2015cites this paper
• The Role Of Sertonin And Vesicular Monoamine Transporters In The Adverse Responses To Methylenedioxymethamphetamine

  2014cites this paper
• Modeling chronic brain exposure to amphetamines using primary rat neuronal cortical cultures.

  2014influential citation
• The preclinical pharmacology of mephedrone; not just MDMA by another name

  2014cites this paper
• Repeated doses of methylone, a new drug of abuse, induce changes in serotonin and dopamine systems in the mouse

  2014cites this paper
• "Ecstasy"-induced toxicity in SH-SY5Y differentiated cells: role of hyperthermia and metabolites

  2014cites this paper
• The mixture of "ecstasy" and its metabolites impairs mitochondrial fusion/fission equilibrium and trafficking in hippocampal neurons, at in vivo relevant concentrations.

  2014cites this paper
• Mixtures of 3,4‐methylenedioxymethamphetamine (ecstasy) and its major human metabolites act additively to induce significant toxicity to liver cells when combined at low, non‐cytotoxic concentrations

  2014cites this paper
• The Synthesis and in Vitro Toxicological Evaluation of the Mitoxantrone Naphthoquinoxaline Metabolite: A Comparative Study with the Parent Drug

  2014influential citation
• Brain and Peripheral Organ Toxicity of "Ecstasy" in Adolescent Rats in Human Relevant Doses

  2014cites this paper
• Neuronal Mitochondrial Trafficking Impairment: The Cause or a Consequence of Neuronal Dysfunction Caused by Amphetamine-Like Drugs

  2014cites this paper
• Nervous about developments in electron transfer-reactive oxygen species-oxidative stress mechanisms of neurotoxicity?

  2014cites this paper
• Nuevas drogas psicoestimulantes. Estudio farmacológico y neurotoxicológico de la metilona

  2014cites this paper
• An in vitro approach to assessing a potential drug interaction between MDMA (ecstasy) and caffeine.

  2014cites this paper
• Ecstasy¿s Neurotoxicity: In Vitro Findings from Mitochondria to the Cell

  2013influential citation
• Study of the toxicological interactions between amphetamine designer drugs in the context of polydrug abuse

  2013influential citation
• Cytotoxic effects of amphetamine mixtures in primary hepatocytes are severely aggravated under hyperthermic conditions.

  2013cites this paper
• Methylenedioxymethamphetamine-induced neurotoxicity: The role of hepatic enzymes cytochrome p450 2d6 and catechol-o-methyltransferase and contribution of microglia

  2013cites this paper
• The mixture of “ecstasy” and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations

  2013cites this paper
• The neurotoxicity of hallucinogenic amphetamines in primary cultures of hippocampal neurons.

  2013cites this paper
• EFFECTS OF ACUTE AND CHRONIC TREATMENT WITH 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) AND THE CANNABINOID RECEPTOR AGONIST WIN55,212-2 ON BEHAVIOUR AND COGNITION IN RATS

  2012influential citation
• The role of adenosine receptor agonist and antagonist on Hippocampal MDMA detrimental effects; a structural and behavioral study

  2012cites this paper
• The risky cocktail: what combination effects can we expect between ecstasy and other amphetamines?

  2012cites this paper
• Lost in translation: preclinical studies on 3,4‐methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans

  2012cites this paper
• Toxicity of amphetamines: an update

  2012influential citation
• Pro‐oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes

  2012cites this paper
• Comparative neurochemical profile of 3,4-methylenedioxymethamphetamine and its metabolite alpha-methyldopamine on key targets of MDMA neurotoxicity.

  2011cites this paper
• Effect of 3,4-methylenedioxyamphetamine on dendritic spine dynamics in rat neocortical neurons--involvement of heat shock protein 27.

  2011cites this paper
• Contribution of catecholamine reactive intermediates and oxidative stress to the pathologic features of heart diseases.

  2011cites this paper
• Role of catecholamines and reactive oxygen species in the mechanism of oxidative stress-induced heart disease:in vitro studies using fresly isolated rat cardiomyocytes

  2011cites this paper
• Synthesis and in vitro toxicity of 4-MTA , its characteristic clandestine synthesis byproducts and related sulphur substituted α-alkylthioamphetamines

  2010cites this paper
• Metabolic interactions between ethanol and MDMA in primary cultured rat hepatocytes.

  2010cites this paper
• Lysosome-associated membrane protein 1 is a major SSEA-1-carrier protein in mouse neural stem cells.

  2010cites this paper
• Neurotoxicity of ecstasy (MDMA): an overview.

  2010cites this paper
• Prenatal exposure to 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) has lasting consequences on neural development and behavior

  2010cites this paper
• Gas chromatography-ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine.

  2010cites this paper
• Neurotoxicidade da "Ectasy" e dos seus metabolitos em células humanas dopaminérgicas SH-SY5Y

  2010cites this paper
• Synthesis and in vitro toxicity of 4-MTA, its characteristic clandestine synthesis byproducts and related sulfur substituted alpha-alkylthioamphetamines.

  2010cites this paper
• Effects of the endogenous PPAR‐α agonist, oleoylethanolamide on MDMA‐induced cognitive deficits in mice

  2010cites this paper
• MDMA toxicity and pathological consequences: a review about experimental data and autopsy findings.

  2010cites this paper
• Neurotoxicity of "ecstasy" and its metabolites in human dopaminergic differentiated SH-SY5Y cells.

  2010cites this paper
• Cross-functioning between the extraneuronal monoamine transporter and multidrug resistance protein 1 in the uptake of adrenaline and export of 5-(glutathion-S-yl)adrenaline in rat cardiomyocytes.

  2009cites this paper
• On the Mechanisms Underlying 3,4-Methylenedioxymethamphetamine Toxicity: The Dilemma of the Chicken and the Egg

  2009cites this paper
• Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.

  2009cites this paper
• MDMA (Ecstasy) Decreases the Number of Neurons and Stem Cells in Embryonic Cortical Cultures

  2009cites this paper
• Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview

  2009cites this paper
• Acetyl-L-carnitine provides effective in vivo neuroprotection over 3,4-methylenedioximethamphetamine-induced mitochondrial neurotoxicity in the adolescent rat brain.

  2009cites this paper
• Study of the interaction between 3,4 methylenedioximethamphetamine and the endocannabinoid system

  2009cites this paper
• PRECLINICAL STUDY: Ecstasy‐induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A

  2009cites this paper
• Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.

  2008influential citation
• Effect of chronic ethanol exposure on the hepatotoxicity of ecstasy in mice: an ex vivo study.

  2008cites this paper
• Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes

  2008cites this paper
• 3,4-Methylenedioxy-N-methamphetamine (ecstasy) promotes the survival of fetal dopamine neurons in culture.

  2008cites this paper
• Oxidation process of adrenaline in freshly isolated rat cardiomyocytes: Formation of adrenochrome, quinoproteins and Gsh-adduct

  2007cites this paper
• Bacterial plate assays and electrochemical methods: an efficient tandem for evaluating the ability of catechol-thioether metabolites of MDMA ("ecstasy") to induce toxic effects through redox-cycling.

  2007cites this paper
• Monoamine Oxidase-B Mediates Ecstasy-Induced Neurotoxic Effects to Adolescent Rat Brain Mitochondria

  2007cites this paper
• EUROTOXICITY MECHANISMS OF THIOETHER

  2007cites this paper
• Synthesis and cyclic voltammetry studies of 3,4-methylenedioxymethamphetamine (MDMA) human metabolites

  2007cites this paper
• Oxidation process of adrenaline in freshly isolated rat cardiomyocytes: formation of adrenochrome, quinoproteins, and GSH adduct.

  2007cites this paper
• Neurotoxicity mechanisms of thioether ecstasy metabolites.

  2007cites this paper
• Evaluation of GSH adducts of adrenaline in biological samples.

  2007cites this paper
• Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons.

  2007cites this paper
• CYP2D6 increases toxicity of the designer drug 4-methylthioamphetamine (4-MTA).

  2007cites this paper
• Influence of CYP2D6 polymorphism on 3,4-methylenedioxymethamphetamine (‘Ecstasy’) cytotoxicity

  2006cites this paper
• Ecstasy: Are animal data consistent between species and can they translate to humans?

  2006cites this paper
• Mass Spectral and Chromatographic Studies on a Series Of Regioisomers and Isobaric Derivatives Related to Methylenedioxymethamphetamines

  2006cites this paper
• Performance Enhancement and Adverse Consequences of MDMA

  2006cites this paper
• Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia.

  2006cites this paper